Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Kumar Nagiri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|September 25, 2025
FDA-Approved Fluorine-Containing Molecules in 2024: Significance, Synthesis, and Therapeutic ApplicationsMalla Reddy Gannarapu, Ravi Kumar Nagiri, Madhu Desagoni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 1, 2025
Identification and development of cGAS inhibitors and their uses to treat Alzheimer's diseaseJazmin Alarcón-Espósito, Ravi Kumar Nagiri, Li Gan, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
High-Throughput Screening and Initial SAR Studies Identify a Novel Sub-micromolar Potent Human cGAS InhibitorJazmin Alarcón-Espósito, Ravi Kumar Nagiri, Siyu Wang, et al.
ACS Chemical Biology|November 18, 2025
High-Throughput Screening and Initial SAR Studies Identify a Novel Submicromolar Potent Human cGAS InhibitorJazmin Alarcón-Espósito, Ravi Kumar Nagiri, Siyu Wang, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Humanized tauopathy chimeras uncover microglial and lncRNA strategies for neuroprotectionWenhui Qu, Li Fan, Minwoo Wendy Jang, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2026
cGAS inhibition delays TDP-43-driven ALS PathogenesisYajing Liu, Weixi Feng, Abulimiti Aikedan, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsyYige Huang, Li Fan, Man Ying Wong, et al.
Nature Neuroscience|April 24, 2023
Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilienceJoe C Udeochu, Sadaf Amin, Yige Huang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|September 25, 2025
FDA-Approved Fluorine-Containing Molecules in 2024: Significance, Synthesis, and Therapeutic ApplicationsMalla Reddy Gannarapu, Ravi Kumar Nagiri, Madhu Desagoni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 1, 2025
Identification and development of cGAS inhibitors and their uses to treat Alzheimer's diseaseJazmin Alarcón-Espósito, Ravi Kumar Nagiri, Li Gan, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
High-Throughput Screening and Initial SAR Studies Identify a Novel Sub-micromolar Potent Human cGAS InhibitorJazmin Alarcón-Espósito, Ravi Kumar Nagiri, Siyu Wang, et al.
ACS Chemical Biology|November 18, 2025
High-Throughput Screening and Initial SAR Studies Identify a Novel Submicromolar Potent Human cGAS InhibitorJazmin Alarcón-Espósito, Ravi Kumar Nagiri, Siyu Wang, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Humanized tauopathy chimeras uncover microglial and lncRNA strategies for neuroprotectionWenhui Qu, Li Fan, Minwoo Wendy Jang, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2026
cGAS inhibition delays TDP-43-driven ALS PathogenesisYajing Liu, Weixi Feng, Abulimiti Aikedan, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsyYige Huang, Li Fan, Man Ying Wong, et al.
Nature Neuroscience|April 24, 2023
Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilienceJoe C Udeochu, Sadaf Amin, Yige Huang, et al.
Pageof 1